2025-04-14 18:47:14

Pfizer (PFE.N) halted development of its weight-loss drug Danuglipron, saying participants experienced potential drug-induced liver injury.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download